Abcam Events, Online Event
2016-03-02
It has been known for a number of years that dysfunctional mitochondrial energy production is a key pathological feature of Parkinson’s disease (PD). Despite extensive research, why this is still remains unclear. Recent studies have revealed that nicotinamide N-methyltransferase (NNMT) is able to regulate mitochondrial energy production, thus opening a therapeutic avenue for the treatment of PD. This webinar will review: - The mechanics of mitochondrial energy production
- The function and phenotypic expression of NNMT in the PD population
- The effect of NNMT expression upon Complex I activity and energy production
- The various cytotrophic effects of NNMT expression upon the neurone
- The molecular pathways underlying these
REGISTER TODAY to hear Dr Parsons discuss this exciting research in greater detail, and answer your questions during a live Q&A session!
|